NCR2 and Miyoshi myopathy: Also, increased expression of NKp30 (on CD56dim CD16+ subset) and NKp44 (CD56bright CD16- and CD56dim CD16+) and decreased expression of NKp44 (CD56bright CD16-) can be observed on PB NK cells in RR MM, but it is not possible to detect any similar changes in ND MM.